Please provide your email address to receive an email when new articles are posted on . Psoriasis patients who self-administer bimekizumab experienced similar levels of comfort and success with both ...

Behavioral data indicate substantial underuse: ~40% delay epinephrine and 56% of caregivers fear needle-based auto-injectors, ...